While the costs of the two medications are similar, there is research that highlights semaglutide GLP-1 as the more cost-effective option when it comes to weight loss treatment
The primary benefit is awareness
That's a real and meaningful development, and it changes the context for evaluating any product that uses "without needles" or "no injections" as a positioning hook
Pacientes obesos com marca-passos gstricos mostram adaptaes metablicas, o que resulta frequentemente em remisso da diabetes 1 ano
The ones waiting for the trend to become undeniable are ceding that window, and Circanas analysis adds a further layer of urgency: the categories with the steepest GLP-1 spending declines are often the same categories with the most bloated SKU counts, the result of years of incremental product extensions that made sense when volume was growing but become expensive to maintain as demand contracts
If you specifically want brand-name Wegovy or Mounjaro, Ro is not the best fit
